MIRA Pharmaceuticals Says 7-Day Dose-Range Finding Toxicology Studies Of MIRA-55 In Rats And Dogs Completed, Supporting Next Phase Of IND-Enabling Program; Targets IND Submission In Q1 2027

뉴스 본문을 불러오고 있어요.

MIRA Pharmaceuticals Says 7-Day Dose-Range Finding Toxicology Studies Of MIRA-55 In Rats And Dogs Completed, Supporting Next Phase Of IND-Enabling Program; Targets IND Submission In Q1 2027 | 웨이프 WAPE

MIRA Pharmaceuticals Says 7-Day Dose-Range Finding Toxicology Studies Of MIRA-55 In Rats And Dogs Completed, Supporting Next Phase Of IND-Enabling Program; Targets IND Submission In Q1 2027

기사 요약

관련 종목

댓글 —